A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC

Clinical trial NCT05698264 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05698264
Sponsor: Nir Peled
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer EGFR Gene Mutation Immune Checkpoint Inhibitor

Start date: 2023-01-20
Primary completion: 2027-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.